Want to join the conversation?
$BDX 3Q15 Call: Growth in Diabetes Care was 3.4%, reflecting softness in US, due primarily to slowing of conversion from syringes to pen needles & flattening of price trends. Offsetting this, was solid sales in international markets. Pharmaceutical Systems grew 8% reflecting favorable timing of ordering patterns as expected with YTD growth of 3.6%.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!